Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Barnaby E Young, Sapna P Sadarangani & Yee Sin Leo. (2015) The avian influenza vaccine Emerflu. Why did it fail?. Expert Review of Vaccines 14:8, pages 1125-1134.
Read now
Read now
Nicole La Gruta, Anne Kelso, Lorena E Brown, Wiesan Chen, David C Jackson & Stephen J Turner. (2009) Role of CD8+ T-cell immunity in influenza infection: potential use in future vaccine development. Expert Review of Respiratory Medicine 3:5, pages 523-537.
Read now
Read now
Fang He, Selvaraj Madhan & Jimmy Kwang. (2009) Baculovirus vector as a delivery vehicle for influenza vaccines. Expert Review of Vaccines 8:4, pages 455-467.
Read now
Read now
Isabel Leroux-Roels & Geert Leroux-Roels. (2009) Current status and progress of prepandemic and pandemic influenza vaccine development. Expert Review of Vaccines 8:4, pages 401-423.
Read now
Read now
B.C. Mathew, R.S. Daniel & I.W. Campbell. (2008) Swine-Origin Influenza A (H1N1) Pandemic Revisited. Libyan Journal of Medicine 4:3, pages 123-125.
Read now
Read now
Articles from other publishers (34)
Zhuofan Li, Ki‐Hye Kim, Noopur Bhatnagar, Bo Ryoung Park, Subbiah Jeeva, Yu‐Jin Jung, Jannatul Raha, Sang‐Moo Kang & Xinyuan Chen. (2022) Physical radiofrequency adjuvant enhances immune responses to influenza H5N1 vaccination. The FASEB Journal 36:3.
Crossref
Crossref
Céline H. Lemoine, Reviany V. Nidom, Roland Ventura, Setyarina Indrasari, Irine Normalina, Kuncoro Puguh Santoso, Francis Derouet, Christophe Barnier-Quer, Gerrit Borchard, Nicolas Collin & Chairul A. Nidom. (2021) Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned. Vaccines 9:5, pages 461.
Crossref
Crossref
Zhuofan Li, Yiwen Zhao, Yibo Li & Xinyuan Chen. (2021) Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity. Vaccines 9:2, pages 75.
Crossref
Crossref
Tomomi Hashizume-TakizawaMegumi Fuse, Noriko Shinozaki-KuwaharaMasanori SaitoRyoki KobayashiTomoko Kurita-Ochiai. (2019) Nasal Immunization with a Vaccinia Virus-based Pentavalent H5N1 Avian Influenza Vaccine Induces Cellular Immunity in the Respiratory Tract of Mice. International Journal of Oral-Medical Sciences 17:3-4, pages 86-92.
Crossref
Crossref
Tomoko Fujiyuki, Ryo Horie, Misako Yoneda, Takeshi Kuraishi, Fumihiko Yasui, Hyun-jeong Kwon, Keisuke Munekata, Fusako Ikeda, Miho Hoshi, Yuri Kiso, Mio Omi, Hiroki Sato, Hiroshi Kida, Shosaku Hattori, Michinori Kohara & Chieko Kai. (2017) Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys. Scientific Reports 7:1.
Crossref
Crossref
W. A. Keitel & P. A. Piedra. (2013) Influenza A(H5N1) Vaccines: Are We Better Prepared for the Next Pandemic?. Journal of Infectious Diseases 209:1, pages 1-3.
Crossref
Crossref
Jörg Rohde, Ralf Amann & Hanns-Joachim Rziha. (2013) New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus. PLoS ONE 8:12, pages e83802.
Crossref
Crossref
Cátia Sousa Pinto, Baltazar Nunes, Maria João Branco & José Marinho Falcão. (2013) Trends in influenza vaccination coverage in Portugal from 1998 to 2010: effect of major pandemic threats. BMC Public Health 13:1.
Crossref
Crossref
Jonathan S. Nguyen-Van-Tam & Joseph Bresee. 2013. Textbook of Influenza. Textbook of Influenza
453
469
.
Lindomar Pena, Troy Sutton, Ashok Chockalingam, Sachin Kumar, Matthew Angel, Hongxia Shao, Hongjun Chen, Weizhong Li & Daniel R. Perez. (2013) Influenza Viruses with Rearranged Genomes as Live-Attenuated Vaccines. Journal of Virology 87:9, pages 5118-5127.
Crossref
Crossref
S. M. Patel, R. L. Atmar, H. M. El Sahly, K. Guo, H. Hill & W. A. Keitel. (2012) Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes. Journal of Infectious Diseases 206:7, pages 1069-1077.
Crossref
Crossref
Yeu-Chun Kim, Jae-Min Song, Aleksandr S. Lipatov, Seong-O Choi, Jeong Woo Lee, Ruben O. Donis, Richard W. Compans, Sang-Moo Kang & Mark R. Prausnitz. (2012) Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. European Journal of Pharmaceutics and Biopharmaceutics 81:2, pages 239-247.
Crossref
Crossref
James V. RogersJennifer A. PriceMorgan Q.S. WendlingJames P. LongHerbert S. Bresler. (2012) Preliminary MicroRNA Analysis in Lung Tissue to Identify Potential Therapeutic Targets Against H5N1 Infection. Viral Immunology 25:1, pages 3-11.
Crossref
Crossref
Zhongpeng Zhao, Fang Yan, Zhongwei Chen, Deyan Luo, Yueqiang Duan, Penghui Yang, Zhong Li, Daxin Peng, Xiufan Liu & Xiliang Wang. (2011) Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab′)2 against highly pathogenic avian influenza H5N1 in mice. International Immunopharmacology 11:12, pages 2000-2006.
Crossref
Crossref
Jessica A. Belser, Cynthia B. Snider, Nancy J. Cox & Frederick G. Hayden. (2011) XIth International Symposium on Respiratory Viral Infections. Influenza and Other Respiratory Viruses 5:6, pages 443-e457.
Crossref
Crossref
John Steel. (2012) New Strategies for the Development of H5N1 Subtype Influenza Vaccines. BioDrugs 25:5, pages 285-298.
Crossref
Crossref
David W. Scheifele, Brian J. Ward, Marc Dionne, Otto Vanderkooi, Joanne M. Langley, Simon Dobson, Yan Li, Barbara Law & Scott A. Halperin. (2011) Evaluation of Adjuvanted Pandemic H1N12009 Influenza Vaccine After One and Two Doses in Young Children. Pediatric Infectious Disease Journal 30:5, pages 402-407.
Crossref
Crossref
James V. Rogers, Young W. Choi & William R. Richter. (2011) Effect of Drying and Exposure to Vaporous Hydrogen Peroxide on the Inactivation of Highly Pathogenic Avian Influenza (H5N1) on Non-porous Surfaces. Applied Biosafety 16:1, pages 4-8.
Crossref
Crossref
N. Andrews, P. Waight, C.-F. Yung & E. Miller. (2011) Age-Specific Effectiveness of an Oil-in-Water Adjuvanted Pandemic (H1N1) 2009 Vaccine Against Confirmed Infection in High Risk Groups in England. Journal of Infectious Diseases 203:1, pages 32-39.
Crossref
Crossref
Penghui Yang, Chong Tang, Deyan Luo, Zhongpeng Zhan, Li Xing, Yueqiang Duan, Weihong Jia, Daxin Peng, Xiufan Liu & Xiliang Wang. (2010) Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine. Veterinary Microbiology 146:1-2, pages 17-23.
Crossref
Crossref
Chi-Yuan Chen, Hung-Jen Liu, Ching-Ping Tsai, Cheng-Yu Chung, Yung-Shen Shih, Poa-Chun Chang, Yung-Tsung Chiu & Yu-Chen Hu. (2010) Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms. Vaccine 28:48, pages 7644-7651.
Crossref
Crossref
RIMA F. KHABBAZ, STEPHEN M. OSTROFF, JAMES W. LeDUC, ROBIN MOSELEY & JAMES M. HUGHES. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
199
219
.
Eduardo Ruiz‐Hitzky, Margarita Darder, Pilar Aranda, M. Ángeles Martín del Burgo & Gustavo del Real. (2009) Bionanocomposites as New Carriers for Influenza Vaccines. Advanced Materials 21:41, pages 4167-4171.
Crossref
Crossref
R. Bodewes, M.M. Geelhoed-Mieras, J.G.M. Heldens, J. Glover, B.N. Lambrecht, R.A.M. Fouchier, A.D.M.E. Osterhaus & G.F. Rimmelzwaan. (2009) The novel adjuvant CoVaccineHT™ increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro. Vaccine 27:49, pages 6833-6839.
Crossref
Crossref
Tino F. Schwarz, Thomas Horacek, Markus Knuf, Hanns-Gerd Damman, François Roman, Mamadou Dramé, Paul Gillard & Wolfgang Jilg. (2009) Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine 27:45, pages 6284-6290.
Crossref
Crossref
Vernon J. Lee, Mei Yin Tok, Vincent T. Chow, Kai Hong Phua, Eng Eong Ooi, Paul A. Tambyah & Mark I. Chen. (2009) Economic Analysis of Pandemic Influenza Vaccination Strategies in Singapore. PLoS ONE 4:9, pages e7108.
Crossref
Crossref
Deborah Middleton, Steven Rockman, Martin Pearse, Ian Barr, Sue Lowther, Jessica Klippel, David Ryan & Lorena Brown. (2009) Evaluation of Vaccines for H5N1 Influenza Virus in Ferrets Reveals the Potential for Protective Single-Shot Immunization. Journal of Virology 83:15, pages 7770-7778.
Crossref
Crossref
Wagner Quintilio, Flavia S. Kubrusly, Dmitri Iourtov, Cosue Miyaki, Maria Aparecida Sakauchi, Fernanda Lúcio, Sandra de Cássia Dias, Celia S. Takata, Eliane N. Miyaji, Hisako G. Higashi, Luciana C.C. Leite & Isaias Raw. (2009) Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice. Vaccine 27:31, pages 4219-4224.
Crossref
Crossref
Leo L. M. Poon, Y. H. Connie Leung, John M. Nicholls, Pin-Yu Perera, Jack H. Lichy, Masafumi Yamamoto, Thomas A. Waldmann, J. S. Malik Peiris & Liyanage P. Perera. (2009) Vaccinia Virus-Based Multivalent H5N1 Avian Influenza Vaccines Adjuvanted with IL-15 Confer Sterile Cross-Clade Protection in Mice. The Journal of Immunology 182:5, pages 3063-3071.
Crossref
Crossref
Won Suk ChoiWoo Joo Kim. (2009) Vaccine Strategy for Influenza A (H1N1) Pandemic. Infection and Chemotherapy 41:5, pages 259.
Crossref
Crossref
Melanie Saville, Grenville Marsh & Agnes Hoffenbach. (2008) Improving seasonal and pandemic influenza vaccines. Influenza and Other Respiratory Viruses 2:6, pages 229-235.
Crossref
Crossref
Terry Nolan, Peter C. Richmond, Neil T. Formica, Katja Höschler, Maryanne V. Skeljo, Tanya Stoney, Jodie McVernon, Gunter Hartel, Daphne C. Sawlwin, Jillian Bennet, David Ryan, Russell L. Basser & Maria C. Zambon. (2008) Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine 26:50, pages 6383-6391.
Crossref
Crossref
Matthew J. Memoli, David M. Morens & Jeffery K. Taubenberger. (2008) Pandemic and seasonal influenza: therapeutic challenges. Drug Discovery Today 13:13-14, pages 590-595.
Crossref
Crossref
Vincent TK Chow, Paul A Tambyah & Kee Tai Goh. (2008) To Kill a Mocking Bird Flu?. Annals of the Academy of Medicine, Singapore 37:6, pages 451-453.
Crossref
Crossref